Liver Transplant CGM
This investigator initiated study aims to describe continuous glucose monitoring (CGM)
based glycemic metrics after discharge from liver transplant and assess relationship with
glycemic metrics and liver transplant outcomes.
Age: 18 years - 66+
Gender: All
T1D Pregnancy & Me
T1D Pregnancy & Me will partner with pregnant participants living with type 1 diabetes
(T1D) in the United States to collect real-world data on management of T1D in pregnancy.
This is a remote study where participants can complete online surveys and share device
data...
Age: 18 years - 66+
Gender: Female
T1D Pregnancy & Me
T1D Pregnancy & Me will partner with pregnant participants living with type 1 diabetes
(T1D) in the United States to collect real-world data on management of T1D in pregnancy.
This is a remote study where participants can complete online surveys and share device
data...
Age: 18 years - 66+
Gender: Female
A Study of GNTI-122 in Adults Recently Diagnosed With T1D
This is a 78-week single arm, multi-center, Phase 1 study to evaluate the safety,
tolerability, cellular kinetics, and biomarker changes in C-peptide over time of
GNTI-122, an investigational cell therapy manufactured from a participant's own blood
cells in adult par...
Age: 18 - 45 years
Gender: All
HLA Demographics Study in Adults With Type 1 Diabetes
This is a study to evaluate the HLA-DRB1*04:01 genotype in adults that have been diagnosed with type 1 diabetes
Age: 18 - 45 years
Gender: All
HLA Demographics Study in Adults With Type 1 Diabetes
This is a study to evaluate the HLA-DRB1*04:01 genotype in adults that have been
diagnosed with type 1 diabetes
Age: 18 - 45 years
Gender: All
Validating CGM for GDM
This is a prospective pilot study to assess the validity of using a continuous glucose
monitor (CGM) in diagnosing gestational diabetes mellitus (GDM). Pregnant individuals
between the ages of 18-50 years old receiving prenatal care at Mount Sinai Hospital
(e..g, E-L...
Age: 18 - 50 years
Gender: Female
Innovative Automated Insulin Delivery System for Type 2 Diabetes
The goal of this clinical trial is to learn if the twiist insulin delivery system works
to treat adults with insulin-treated type 2 diabetes.
Age: 18 years - 66+
Gender: All
Innovative Automated Insulin Delivery System for Type 2 Diabetes
The goal of this clinical trial is to learn if the twiist insulin delivery system works to treat adults with insulin-treated type 2 diabetes.
Age: 18 years - 66+
Gender: All
Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes
Pregnant women aged 18-40 with gestational diabetes (GDM) will take part in this study.
We want to see how two different insulin treatments affect their blood sugar after they
eat. These women usually use a rapid-acting insulin analog (RAA) that's injected to
control...
Age: 18 - 40 years
Gender: Female
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
The main purpose of this study is to determine if retatrutide can significantly lower the
incidence of serious heart-related complications or prevent the worsening of kidney
function. The trial will enroll adults with body mass index 27 kg/m^2 or higher and
Atheroscl...
Age: 45 years - 66+
Gender: All
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
The main purpose of this study is to determine if retatrutide can significantly lower the
incidence of serious heart-related complications or prevent the worsening of kidney
function. The trial will enroll adults with body mass index 27 kg/m^2 or higher and
Atheroscl...
Age: 45 years - 66+
Gender: All
Cholesterol Lowering and Residual Risk in Diabetes, Type 1
This is a prospective, interventional, cohort study, meaning that researchers will follow
and observe a group of enrolled study participants over a period of time (one to two
months) to gather information and record any developments of the outcomes in question.
Thi...
Age: 18 - 89 years
Gender: All
Cholesterol Lowering and Residual Risk in Diabetes, Type 1
This is a prospective, interventional, cohort study, meaning that researchers will follow
and observe a group of enrolled study participants over a period of time (one to two
months) to gather information and record any developments of the outcomes in question.
Thi...
Age: 18 - 89 years
Gender: All
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
The purpose of this study is to assess the safety and efficacy (including durability) of
up to 2 REACT injections given 3 months (+30 days) apart and delivered percutaneously
into biopsied and non-biopsied contralateral kidneys in participants with T2DM and CKD.
Age: 30 - 80 years
Gender: All
Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control as a Means of Improving Glycemic Control in Adults With Type 2 Diabetes Mellitus
Trial Title A randomized, double blind sham controlled clinical trial to evaluate the
efficacy of vestibular nerve stimulation (VeNS), together with a lifestyle modification
program, compared to a sham control with a lifestyle modification program, as a means of
i...
Age: 22 - 70 years
Gender: All
Prediabetes and Type 2 Diabetes Data Collection Study
To collect data in an observational study from Prediabetes (PD) and Type 2 Diabetes (T2D)
patients including time correlated CGM, medication and food intake approximately 80% of the
time for each subject that completes the entire active phase.
Age: 18 years - 66+
Gender: All
Evaluation of the Efficacy and Safety of Duodenal Mucosal Resurfacing Using the Revita® System in Subjects With Type 2 Diabetes on Insulin Therapy
The Revita® system is being investigated to assess the efficacy of DMR versus Sham on improvement in Glycemic, Hepatic and Cardiovascular endpoints for patients with Type 2 Diabetes who are inadequately controlled with insulin therapy. The purpose of this study is t...
Age: 21 - 70 years
Gender: All
Longitudinal Observation of Insulin Requirements and Sensor Use in Pregnancy
The overall goal of this study is to enroll pregnant women with type 1 diabetes and follow their glycemic outcomes prospectively throughout pregnancy and into the post-partum period. The investigators anticipate that when compared to subjects using an Artificial pancrea...
Age: 18 - 40 years
Gender: Female
EMPEROR-HF: A phase III randomised, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart Failure with reduced Ejection Fraction (HFrEF)
Chronic heart failure (HF) is a progressive syndrome characterized by the inability of the heart to provide adequate blood supply to meet the metabolic demand of different tissues or to be able to do so only at the expense of elevated left ventricle filling pressure. HF...
Age: 18 - 45 years
Gender: All